April 29 Quick Takes: Sirnaomics, Codiak, Cortexyme, Milestone, NextCure, Applied Therapeutics, Magenta

Sirnaomics closes $47M series C
RNAi therapeutics company Sirnaomics Inc. (Gaithersburg, Md.) raised $22 million in a series C2 round led by Hong Kong-based CR-CP Life Sciences Fund, closing out its series C round for a total of $47 million. Rich Yield Capital, Rolling Boulder Investment and Legend Sky Investment also invested (see "Sirnaomics Raises $25M Series C1 Round").

Codiak files for IPO
Exosome therapeutics company Codiak BioSciences Inc. (Cambridge, Mass.) proposed to raise up to $86.3 million in a NASDAQ IPO underwritten by Jefferies, Evercore ISI, William Blair and Wedbush PacGrow...